Transcription of 乳がんの生物学的特徴 - csp.or.jp
{{id}} {{{paragraph}}}
State of the art 15 2007/9/23 24 1 9 23 ( )CSPOR CRC 2 ( )3 80% (ER) (PgR) ER PgR ER PgR ER PgR HER2 20% HER2 HER2 HER2 HER2 LH-RH 6 CH3 OHHO OOHCH3CH3 state of the art 15 2007/9/23 24 27 = 8 = 1aminoglutethimide( testolacotone( 2fadrozole ( )formestane3anastrozole ( )letrozole ( ) exemestane( )10 = ER(++), PgR(++), HER2(-) : ER PgR HER2 ER(-), PgR(-), HER2(+).))
(渡辺亨) 第15回CSPOR・CRCセミナ―(2007/9/23~24) 使用目的を研究者の自己学習用に限り,その他への転用を禁じる 2
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}